Search for: "DOE et al v. JANSSEN THERAPEUTICS et al" Results 1 - 5 of 5
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
9 Jan 2022, 1:45 am by Rose Hughes
Chimeric antigen receptor (CAR) T-cell therapy is a revolutionary form of immunotherapy in which a patient's own T cells are reprogrammed to target harmful (e.g. cancer) cells (Singh et al.). [read post]
18 Apr 2012, 1:29 pm by Bexis
Janssen Pharmaceuticals, Inc., 951 N.E.2d 1238 (Ill. [read post]
23 Aug 2008, 1:23 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: DRM for streaming music dies a quiet death: (Electronic Frontier Foundation), (Techdirt) CAFC decides Apotex and Impax infringed AstraZeneca’s Prilosec patents: (Law360), (Patent Prospector), (Patent Docs), (GenericsWeb), CAFC upholds lower court’s decision finding USPTO was within its rights to subject a Cooper patent to… [read post]